[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"gastric-cancer-patients-undergoing-gastrectomy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:gastric-cancer-patients-undergoing-gastrectomy":103},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,45,72],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":26,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100612189",false,"NCT07250347","AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CT","Langue and Imaging-integrated Foundation Model for Gastric Cancer Detection and Staging Via Contrast-Enhanced CT: a Multicenter Study","Inclusion Criteria:\n\n1. pathologically confirmed gastric cancer;\n2. preoperative contrast-enhanced CT performed;\n3. no evidence of distant metastasis on baseline staging;\n4. curative-intent management with complete postoperative histopathology.\n\nExclusion Criteria:\n\n1. prior treatment before surgery;\n2. non-diagnostic or poor-quality CT precluding evaluation.","ALL","18 Years","85 Years",{"count":19,"type":20},8000,"ESTIMATED","OBSERVATIONAL","Accurate preoperative assessment of gastric cancer stage guides eligibility for endoscopic resection, extent of gastrectomy and lymphadenectomy, selection for neoadjuvant therapy, and use of staging laparoscopy. Contrast-enhanced CT (CECT) is guideline-endorsed for initial staging, yet performance varies across institutions and readers. This study will evaluate an artificial-intelligence (AI) system that analyzes routine CECT to detect gastric cancer and assign four-class T stage (T1-T4) and N stage (N0-N3) .",[24,25],"Gastric Cancer Stage","Gastric Cancer Patients Undergoing Gastrectomy",[27,28,29,30,31],"Gastric cancer","stage","artificial-intelligence","detection","contrast-enhanced CT","RECRUITING","2025-11-24",{"date":35,"type":36},"2025-11-26","ACTUAL",{"date":38,"type":36},"2025-08-01",{"date":40,"type":20},"2028-12-30",{"name":42,"class":43},"The First Affiliated Hospital with Nanjing Medical University","OTHER",1,{"id":46,"slug":4,"hasResults":10,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":54,"phases":55,"briefSummary":57,"conditions":58,"keywords":59,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":44},"100611172","NCT07237126","Single-port Robotic Radical Gastrectomy for Gastric Cancer","Efficacy and Safety Assessment of Single-port Robotic Radical Gastrectomy for Gastric Cancer: a Phase 2a Trial Based on the IDEAL Framework","Inclusion Criteria:\n\n* (1) Age: 18-75 years; (2) Histologically confirmed gastric adenocarcinoma by endoscopic biopsy; (3) Preoperatively staged as either endoscopically unresectable T1, or cT2-4a with or without nodal involvement (N-\u002F+), and no distant metastasis (M0), according to the 7th edition of the AJCC Cancer Staging Manual; (4) Eligible for potentially curative surgical resection; (5) Eastern Cooperative Oncology Group (ECOG) performance status score of 0-1; (6) American Society of Anesthesiologists (ASA) physical status classification of I-III; (7) Provision of written informed consent.\n\nExclusion Criteria:\n\n* (1) Pregnant or lactating women; (2) Severe psychiatric disorder; (3) History of prior upper abdominal surgery; (4) Previous gastrectomy, endoscopic submucosal dissection (ESD), or endoscopic mucosal resection (EMR); (5) Preoperative imaging showing regional lymphadenopathy with lymph node(s) larger than 3 cm in diameter; (6) History of another primary malignancy within the past 5 years; (7) Prior neoadjuvant chemotherapy or radiotherapy; (8) History of cerebrovascular or cardiovascular event (e.g., stroke or myocardial infarction) within the past 6 months; (9) Systemic corticosteroid use for more than one month within the past month; (10) Requirement for concomitant surgery for other conditions; (11) Need for emergency surgery due to gastric cancer-related complications (e.g., bleeding, obstruction, or perforation); (12) Participation in another interventional clinical trial previously; (13) Active severe infectious disease; (14) Severe systemic disease.","75 Years",{"count":53,"type":20},20,"INTERVENTIONAL",[56],"NA","This study is a single-center, phase 2a exploratory clinical study based on IDEAL framework. The intraoperative and postoperative complications were analyzed to evaluate the safety, feasibility and clinical efficacy of single-port robot-assisted gastric tumor resection.",[25],[60,27,61],"Single-port robotic","Radical Gastrectomy","NOT_YET_RECRUITING","2025-11-16",{"date":65,"type":36},"2025-11-19",{"date":67,"type":20},"2025-11-20",{"date":69,"type":20},"2027-11-20",{"name":71,"class":43},"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University",{"id":73,"slug":4,"hasResults":10,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":4,"eligibilityCriteria":77,"healthyVolunteers":10,"sex":15,"minAge":78,"maxAge":79,"enrollmentInfo":80,"targetDuration":4,"studyType":54,"phases":82,"briefSummary":83,"conditions":84,"keywords":89,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":44},"100608461","NCT07201857","Peri-habilitation for Patients With Gastric Cancer","Peri-habilitation to Enhance Treatment Outcomes and Postoperative Recovery in Patients With Gastric Cancer","Inclusion Criteria:\n\n* Patients aged 65 years or older who have been diagnosed with gastric cancer and are scheduled to undergo surgical treatment or chemotherapy.\n\nExclusion Criteria:\n\n* Patients with severe conditions who are unable to undergo the intervention prior to surgical treatment or chemotherapy.\n* Patients with physical (e.g., musculoskeletal) or mental disorders that make participation in or continuation of the program impossible.\n* Patients judged to be at risk of additional physical burden from the intervention.","65 Years","90 Years",{"count":81,"type":20},30,[56],"This study aims to evaluate the clinical applicability of a peri-habilitation program in patients with gastric cancer by applying nutritional intervention for approximately two weeks before surgery and a combined exercise and nutrition intervention for about three weeks after hospital discharge, and by analyzing its effects on the prevention of postoperative complications and recovery.",[85,86,25,87,88],"Gastric Cancer (Diagnosis)","Gastric Cancer Patient","Gastric Cancer Patients Undergoing Minimally Invasive Gastrectomy","Gastric Cancer Patients Undergoing Laparoscopic Gastrectomy",[90,91,92,93],"peri-habilitation","gastric cancer","postoperative recovery","exercise intervention","2025-09-23",{"date":96,"type":36},"2025-10-01",{"date":98,"type":20},"2025-10-15",{"date":100,"type":20},"2026-12-31",{"name":102,"class":43},"Korea University Anam Hospital",""]